• Home
  • Stock
  • Eris Lifesciences Fundamental Analysis
  • Eris Lifesciences Fundamental Analysis

Eris Lifesciences fundamental analysis

ERIS

HealthcareLarge

1593

2.40 (-0.15%)
Last updated on 28 Nov, 2025 | 15:29 IST
BUYSELL

The current prices are delayed, login to your account for live prices

Eris Lifesciences Fundamentals

P/E Ratio

52.28

P/B Ratio

7.03

Div. Yield

0.46

Sector P/E

37.14

Sector P/B

0.85

Sec. Div. Yield

0.56

  • Eris Lifesciences Fundamentals is currently trading with a P/E Ratio of 52.28, compared to the sector average of 37.14. Its P/B Ratio stands at 7.03, while the sector’s is 0.85. In terms of returns, the stock offers a Dividend Yield of 0.46%, which is than the sector’s 0.56%.

Eris Lifesciences Score Card

  • Price

    Attractive

  • Growth

    Average

  • Quality

    Good

  • Management

    Good

  • On its scorecard, Eris Lifesciences reflects: Price – Attractive, Growth – Average, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.